P1177: PROGNOSTIC VALUE OF TP53 VARIANTS IN CHILDREN WITH MATURE B-CELL LYMPHOMA TREATED ACCORDING TO REDUCED-INTENSITY B-NHL-2010M PROTOCOL

• V. Egor,
• A. Yuliya,
• K. Brenning,
• A. Itov,
• D. Abramov,
• A. Sharlai,
• M. Senchenko,
• D. Konovalov,
• G. Novichkova,
• N. Miakova

Affiliations

V. Egor

1 Oncohematology

A. Yuliya

1 Oncohematology

K. Brenning

1 Oncohematology

A. Itov

1 Oncohematology

D. Abramov

2 Pathology, Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

A. Sharlai

2 Pathology, Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

M. Senchenko

2 Pathology, Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

D. Konovalov

2 Pathology, Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

G. Novichkova

1 Oncohematology

N. Miakova

1 Oncohematology